Acute Corneal Epithelial Rejection of LR-CLAL After SARS-CoV-2 Vaccination
Conclusions:
The novel SARS-CoV-2 vaccine upregulates the immune system to produce an adaptive immune response. The SARS-CoV-2 vaccine may potentially be associated with increased risk of rejection in those with ocular surface transplants.
Source: Cornea - Category: Opthalmology Tags: Case Report Source Type: research
More News: Bone Graft | Corneal Transplant | Coronavirus | Covid Vaccine | COVID-19 | Opthalmology | Respiratory Medicine | SARS | Study | Transplants | Vaccines